Laboratorios Farmaceuticos Rovi, S.A. (BIT:1ROVI)

BIT:1ROVI Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr 15, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	2,508	3,220	3,213	1,925	4,138	2,099
Market Cap Growth	0.22%	0.22%	66.93%	-53.49%	97.10%	55.36%
Enterprise Value	2,604	3,340	3,223	1,902	4,066	2,139
PE Ratio	18.33	23.52	18.86	9.64	27.03	34.38
PS Ratio	3.28	4.22	3.87	2.35	6.38	5.00
PB Ratio	4.31	5.54	5.91	3.69	8.79	5.62
P/TBV Ratio	4.61	5.92	6.28	3.92	9.42	6.18
P/FCF Ratio	31.69	40.68	54.04	10.30	37.89	278.47
P/OCF Ratio	18.14	23.29	28.37	8.10	27.69	44.79
EV/Sales Ratio	3.41	4.37	3.89	2.33	6.27	5.09
EV/EBITDA Ratio	12.67	16.73	13.54	7.01	20.69	23.87
EV/EBIT Ratio	14.58	18.69	14.69	7.50	22.57	28.55
EV/FCF Ratio	32.90	42.20	54.22	10.18	37.23	283.73
Debt / Equity Ratio	0.20	0.20	0.12	0.14	0.16	0.20
Debt / EBITDA Ratio	0.56	0.56	0.27	0.26	0.36	0.80
Debt / FCF Ratio	1.45	1.45	1.10	0.39	0.67	9.87
Asset Turnover	0.94	0.94	0.99	1.01	0.99	0.77
Inventory Turnover	0.89	0.89	1.07	1.10	1.14	0.95
Quick Ratio	0.99	0.99	0.83	1.04	1.35	1.10
Current Ratio	3.13	3.13	2.55	2.12	2.66	2.97
Return on Equity (ROE)	24.33%	24.33%	31.99%	40.24%	36.24%	17.54%
Return on Assets (ROA)	13.69%	13.69%	16.34%	19.68%	17.23%	8.63%
Return on Capital (ROIC)	17.12%	17.12%	22.81%	27.88%	22.69%	10.95%
Return on Capital Employed (ROCE)	26.50%	26.50%	36.60%	43.40%	33.20%	16.60%
Earnings Yield	545.70%	4.25%	5.30%	10.37%	3.70%	2.91%
FCF Yield	315.58%	2.46%	1.85%	9.71%	2.64%	0.36%
Payout Ratio	4124.09%	41.24%	40.54%	25.55%	13.80%	15.89%
Buyback Yield / Dilution	372.60%	3.73%	0.51%	3.50%	-0.03%	-0.37%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.